Literature DB >> 25730519

Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination.

April M Young1, Daniel S Halgin, Jennifer R Havens.   

Abstract

Formative research into the behavioral factors surrounding HIV vaccine uptake is becoming increasingly important as progress is made in HIV vaccine development. Given that the first vaccines on the market are likely to be partially effective, risk compensation (i.e., increased risk behavior following vaccination) may present a concern. This study characterized the relationships in which HIV vaccine-related risk compensation is most likely to occur using dyadic data collected from people who use drugs, a high-risk group markedly underrepresented in extant literature. Data were collected from 433 drug users enrolled in a longitudinal study in the USA. Respondents were asked to provide the first name and last initial of individuals with whom they had injected drugs and/or had sex during the past six months. For each partner, respondents reported their likelihood of increasing risk behavior if they and/or their partner received an HIV vaccine. Using generalized linear mixed models, relationship-level correlates to risk compensation were examined. In bivariate analysis, risk compensation was more likely to occur between partners who have known each other for a shorter time (odds ratio [OR]=0.95, 95% confidence interval [CI]: 0.90-0.99, p=0.028) and between those who inject drugs and have sex together (OR=2.52, CI: 1.05-6.04, p=0.039). In relationships involving risk compensation, 37% involved partners who had known each other for a year or less compared to only 13% of relationships not involving risk compensation. Adjusting for other variables, duration (OR: 0.95, CI: 0.90-1.00, p=0.033) was associated with risk compensation intent. These analyses suggest that risk compensation may be more likely to occur in less established relationships and between partners engaging in more than one type of risk behavior. These data provide further support for the need to expand measures of risk compensation in HIV vaccine preparedness studies to assess not only if people will change their behavior, but also with whom.

Entities:  

Keywords:  HIV vaccine; condom use; injection drug use; risk compensation; social network

Mesh:

Substances:

Year:  2015        PMID: 25730519      PMCID: PMC4425595          DOI: 10.1080/09540121.2015.1017443

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  23 in total

1.  A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand.

Authors:  Peter A Newman; Surachet Roungprakhon; Suchon Tepjan; Suzy Yim; Rachael Walisser
Journal:  Glob Public Health       Date:  2012-07-10

2.  HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents.

Authors:  P M Webb; G D Zimet; R Mays; J D Fortenberry
Journal:  J Adolesc Health       Date:  1999-11       Impact factor: 5.012

3.  Breaking the silence: what homeless 18- to 24-year-olds say about HIV vaccine trials.

Authors:  Deborah Koniak-Griffin; Adeline Nyamathi; Louise Tallen; Evelyn González-Figueroa; Ernestina Dominick
Journal:  J Health Care Poor Underserved       Date:  2007-08

4.  Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

Authors:  Jacqueline M O'Connell; Robert S Hogg; Keith Chan; Steffanie A Strathdee; Nancy McLean; Steve L Martindale; Brian Willoughby; Robert Remis
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

5.  Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.

Authors:  Catherine L Macphail; Jennifer N Sayles; William Cunningham; Peter A Newman
Journal:  Qual Health Res       Date:  2012-01-04

6.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Authors:  Jennifer R Havens; Michelle R Lofwall; Simon D W Frost; Carrie B Oser; Carl G Leukefeld; Richard A Crosby
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

7.  Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).

Authors:  Peter A Newman; Sung-Jae Lee; Naihua Duan; Ellen Rudy; Terry K Nakazono; John Boscardin; Lisa Kakinami; Steven Shoptaw; Allison Diamant; William E Cunningham
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402

8.  Network structure and the risk for HIV transmission among rural drug users.

Authors:  A M Young; A B Jonas; U L Mullins; D S Halgin; J R Havens
Journal:  AIDS Behav       Date:  2013-09

9.  Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensation.

Authors:  April M Young; Daniel S Halgin; Ralph J DiClemente; Claire E Sterk; Jennifer R Havens
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

View more
  1 in total

Review 1.  Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned.

Authors:  April M Young; Abby E Rudolph; Jennifer R Havens
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.